Wanbury Ltd

₹ 223 -1.85%

24 Oct - close price

About

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research^[1]

Key Points

Business Overview:^[1]
WL is a pharmaceutical company with a presence in the API global market and domestic branded Formulation. It’s majorly into Active Pharmaceutical Ingredient (API) Sales & Marketing in over 50 countries and Pan-India
Formulation presence

Website BSE NSE - BE

Market Cap ₹ 730 Cr.
Current Price ₹ 223
High / Low ₹ 291 / 87.9
Stock P/E 27.1
Book Value ₹ 6.70
Dividend Yield 0.00 %
ROCE 62.5 %
ROE %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has delivered good profit growth of 27.4% CAGR over last 5 years

Cons

Stock is trading at 33.2 times its book value
Company has low interest coverage ratio.
The company has delivered a poor sales growth of 7.34% over past five years.
Promoters have pledged 76.7% of their holding.
Earnings include an other income of Rs.28.9 Cr.
Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	127.86	124.09	124.84	134.39	116.94	123.96	125.78	132.98	146.29	144.46	145.50	139.41	131.11
	121.32	116.99	115.99	121.58	119.99	118.36	119.33	118.83	132.94	127.12	124.35	121.24	120.13
Operating Profit	6.54	7.10	8.85	12.81	-3.05	5.60	6.45	14.15	13.35	17.34	21.15	18.17	10.98
OPM %	5.11%	5.72%	7.09%	9.53%	-2.61%	4.52%	5.13%	10.64%	9.13%	12.00%	14.54%	13.03%	8.37%
	0.31	0.31	0.25	77.01	1.94	0.78	0.26	-2.65	0.62	0.76	0.69	26.48	0.94
Interest	5.02	5.16	5.64	4.79	3.31	3.94	6.63	7.51	5.79	7.67	8.26	7.46	7.59
Depreciation	2.64	2.78	3.03	3.00	3.03	3.15	3.13	3.07	3.18	3.24	3.32	3.28	3.29
Profit before tax	-0.81	-0.53	0.43	82.03	-7.45	-0.71	-3.05	0.92	5.00	7.19	10.26	33.91	1.04
Tax %	7.41%	11.32%	13.95%	-0.62%	-2.82%	25.35%	7.54%	-10.87%	6.00%	-2.50%	-0.19%	0.80%	0.00%
	-0.86	-0.58	0.37	82.54	-7.24	-0.89	-3.28	1.02	4.69	7.36	10.27	33.63	1.04
EPS in Rs	-0.26	-0.18	0.11	25.27	-2.21	-0.27	-1.00	0.31	1.43	2.25	3.14	10.27	0.32
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2013	Sep 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	459	661	250	420	432	370	391	367	392	511	485	557	560
	491	637	228	387	414	438	375	344	374	475	459	484	493
Operating Profit	-32	25	21	33	19	-68	16	23	18	36	26	73	68
OPM %	-7%	4%	9%	8%	4%	-18%	4%	6%	5%	7%	5%	13%	12%
	5	-78	6	0	90	76	9	84	2	77	-3	26	29
Interest	37	48	19	32	36	31	40	33	23	21	21	29	31
Depreciation	23	23	5	9	10	10	10	10	10	11	12	13	13
Profit before tax	-87	-125	4	-7	62	-32	-25	65	-12	81	-10	56	52
Tax %	0%	2%	28%	0%	1%	-1%	-1%	0%	2%	-0%	1%	1%
	-87	-128	3	-7	62	-32	-25	64	-13	81	-10	56	52
EPS in Rs	-50.19	-63.95	1.60	-3.58	26.71	-13.49	-10.48	25.79	-5.04	24.94	-3.18	17.09	15.98
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	7%
3 Years:	12%
TTM:	6%

Compounded Profit Growth
10 Years:	%
5 Years:	27%
3 Years:	68%
TTM:	1165%

Stock Price CAGR
10 Years:	17%
5 Years:	78%
3 Years:	45%
1 Year:	156%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2013	Sep 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	17	20	20	20	23	24	24	25	25	33	33	33
Reserves	-65	-212	-214	-209	-176	-208	-233	-168	-181	-56	-66	-11
	415	389	381	362	300	250	260	190	192	100	95	116
	406	209	209	215	265	207	236	232	253	276	241	205
Total Liabilities	773	406	396	388	412	273	286	279	289	353	304	343
	423	174	164	180	186	178	172	164	167	167	167	167
CWIP	25	13	19	14	10	10	9	14	11	2	2	3
Investments	1	0	0	0	0	0	0	0	0	0	0	0
	324	219	213	193	216	84	105	101	111	183	135	174
Total Assets	773	406	396	388	412	273	286	279	289	353	304	343

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2013	Sep 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	87	68	40	43	43	32	30	44	17	41	20	4
	-21	-6	-5	-20	-13	-1	-3	64	8	1	-9	-17
	-64	-71	-30	-28	-27	-33	-27	-108	-17	-29	-32	15
Net Cash Flow	3	-9	5	-5	3	-2	-0	-0	7	13	-21	2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2013	Sep 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	67	57	144	65	71	29	41	50	32	45	52	59
Inventory Days	63	42	103	69	63	27	36	25	41	60	26	43
Days Payable	114	113	301	172	260	174	209	253	221	218	179	196
Cash Conversion Cycle	15	-14	-55	-38	-125	-118	-131	-177	-148	-113	-101	-94
Working Capital Days	-159	-3	-26	-45	-132	-195	-175	-212	-168	-103	-102	-20
ROCE %	-11%	4%		12%	57%	-1%	26%	31%	27%	46%	21%	62%

Shareholding Pattern

Numbers in percentages

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	39.89%	39.89%	39.85%	39.85%	39.84%	39.84%	39.84%	39.80%	39.79%	39.79%	39.79%	39.77%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.18%	0.22%	1.02%
	60.11%	60.11%	60.15%	60.16%	60.16%	60.16%	60.16%	60.19%	60.20%	60.02%	59.97%	59.21%
No. of Shareholders	11,619	11,289	11,398	11,555	11,888	11,911	11,741	11,634	11,616	13,087	14,400	17,199

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
	56.11%	54.93%	54.93%	52.13%	52.09%	39.89%	39.84%	39.79%	39.77%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.18%	1.02%
	2.43%	2.26%	2.26%	2.14%	1.13%	0.00%	0.00%	0.00%	0.00%
	41.46%	42.81%	42.81%	45.73%	46.78%	60.11%	60.16%	60.02%	59.21%
No. of Shareholders	17,556	17,088	12,831	12,494	11,831	11,289	11,911	13,087	17,199

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Wanbury Ltd

Wanbury Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings